Consistent evidence from in vitro and in vivo studies demonstrate endocrine disorders, metabolic imbalance, and cardiovascular defects are all characterized by imbalance in the Insulin-like growth factor-1 (IGF-1) hormone and its affiliated signaling [18,19,20,21,22,23,24,25,26,27,28]. This evidence concerns the gene IGF1 and endocrine system disorder.